MIA
GILD icon

MeadowBrook Investment Advisors’s Gilead Sciences GILD Stock Holding History

MeadowBrook Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Hold
435
– – 0.04% 189
2026
Q1 		$60.6K Hold
435
– – 0.05% 171
2025
Q4 		$53.4K Buy
+435
New +$52.9K 0.05% 190
2025
Q3 		– Sell
-460
Closed -$51K – 199
2025
Q2 		$51K Sell
460
-25
-5% -$2.66K 0.05% 181
2025
Q1 		$54.3K Sell
485
-615
-56% -$63.5K 0.05% 172
2024
Q4 		$102K Sell
1,100
-20
-2% -$1.8K 0.09% 149
2024
Q3 		$93.9K Sell
1,120
-45
-4% -$3.43K 0.08% 139
2024
Q2 		$79.9K Hold
1,165
– – 0.08% 148
2024
Q1 		$85.3K Hold
1,165
– – 0.08% 146
2023
Q4 		$94.4K Buy
+1,165
New +$90.7K 0.09% 138

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

MeadowBrook Investment Advisors's GILD Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 435 shares worth $55K. The position accounts for 0.04% of the portfolio, ranked #189.

MeadowBrook Investment Advisors first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $102K in Q4 2024. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MeadowBrook Investment Advisors held 435 shares of Gilead Sciences worth $55K as of Q2 2026.
  • MeadowBrook Investment Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #189 holding.
  • MeadowBrook Investment Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • MeadowBrook Investment Advisors's Gilead Sciences position peaked at $102K in Q4 2024.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.